Logical parameters, a paired (intra-individual) analysis of the patients in the control and intervention group was carried out. Results from the beginning of the study were compared to those at its end. A significant improvement in the diabetes self-efficacy domain was depicted in the intervention group. This clinically means that children and adolescents with type-1 diabetes mellitus who used Mobil Diab have higher ability of implementing their own individual therapy demands. In the control group, no significant change in the psychological parameters was observed, Table 3.J. Pers. Med. 2014, 4 3.3. Usability and Acceptance of “Mobil Diab”Children and adolescents with type-1 diabetes mellitus who used Mobil Diab (intervention group) were to rate the telemedical system. For this purpose, a scale of 1.0 (=very good), 2.0 (=good), 3.0 (=average) to 4.0 (=not good) was used. The following are the results from 30/34 (88 ) of the children and teens (4 (12 ) of subjects did not take part in this survey). The results of the questionnaire for the investigation of usability and acceptance of Mobil Diab telemedical application generally show good acceptance of the system, Table 4. Moreover, the 7 members of the medical staff who took part in the trial found the system to be helpful and time saving in analyzing patients’ data. Graphical and statistical tools integrated to the system helped them monitor some trends and draw some quick conclusions. Interaction with the patient was also easy and valuable. Benefits and some drawbacks of the system were identified by the patients and medical staff involved in the study and can be summarized as follows: ?Benefits for the patients include among others: unimpeded patient mobility, data input via smart phones and/or via web, regular self-control of diabetes-related data enables the right care to be administrated at the right time, potential to improve care process and quality of service, improvement of patients’ POR-8MedChemExpress Ornipressin motivation through their involvement in the therapy process, reduced check-up frequency to doctors, use of mobile LCZ696MedChemExpress LCZ696 health technologies encourages diabetes patients to change their behavior/lifestyle and improve their health. Benefits for the health care staff involves among others the following: complete and regular data input, which is helpful for individual therapy plan, minimization of errors caused by lack of information about the disease history, improvement of the care process quality, getting specialist opinions, access to patients’ data worldwide independent from time and location, automatic alarm message in case of critical data from a patient. Benefits for the health system include among others the following: delay and reduce diabetes complications, minimize hospitalization rates due to diabetes complications, reduce death rates from diabetes, speed up the transition of patients from hospitals to their own homes which leads to a reduction in costs, enable the organization of health information through a structured gathering of all relevant data in one central place. Patients and medical staff were satisfied with the security features implemented to the system. Access to the web and mobile applications was secured by an individual password. Authorization and access to different sectors of the data was determined by the category of the user. A member of the medical staff could only coach and see patients who were allocated to him. A single drawback according to the users was the fact that int.Logical parameters, a paired (intra-individual) analysis of the patients in the control and intervention group was carried out. Results from the beginning of the study were compared to those at its end. A significant improvement in the diabetes self-efficacy domain was depicted in the intervention group. This clinically means that children and adolescents with type-1 diabetes mellitus who used Mobil Diab have higher ability of implementing their own individual therapy demands. In the control group, no significant change in the psychological parameters was observed, Table 3.J. Pers. Med. 2014, 4 3.3. Usability and Acceptance of “Mobil Diab”Children and adolescents with type-1 diabetes mellitus who used Mobil Diab (intervention group) were to rate the telemedical system. For this purpose, a scale of 1.0 (=very good), 2.0 (=good), 3.0 (=average) to 4.0 (=not good) was used. The following are the results from 30/34 (88 ) of the children and teens (4 (12 ) of subjects did not take part in this survey). The results of the questionnaire for the investigation of usability and acceptance of Mobil Diab telemedical application generally show good acceptance of the system, Table 4. Moreover, the 7 members of the medical staff who took part in the trial found the system to be helpful and time saving in analyzing patients’ data. Graphical and statistical tools integrated to the system helped them monitor some trends and draw some quick conclusions. Interaction with the patient was also easy and valuable. Benefits and some drawbacks of the system were identified by the patients and medical staff involved in the study and can be summarized as follows: ?Benefits for the patients include among others: unimpeded patient mobility, data input via smart phones and/or via web, regular self-control of diabetes-related data enables the right care to be administrated at the right time, potential to improve care process and quality of service, improvement of patients’ motivation through their involvement in the therapy process, reduced check-up frequency to doctors, use of mobile health technologies encourages diabetes patients to change their behavior/lifestyle and improve their health. Benefits for the health care staff involves among others the following: complete and regular data input, which is helpful for individual therapy plan, minimization of errors caused by lack of information about the disease history, improvement of the care process quality, getting specialist opinions, access to patients’ data worldwide independent from time and location, automatic alarm message in case of critical data from a patient. Benefits for the health system include among others the following: delay and reduce diabetes complications, minimize hospitalization rates due to diabetes complications, reduce death rates from diabetes, speed up the transition of patients from hospitals to their own homes which leads to a reduction in costs, enable the organization of health information through a structured gathering of all relevant data in one central place. Patients and medical staff were satisfied with the security features implemented to the system. Access to the web and mobile applications was secured by an individual password. Authorization and access to different sectors of the data was determined by the category of the user. A member of the medical staff could only coach and see patients who were allocated to him. A single drawback according to the users was the fact that int.
Nucleoside Analogues nucleoside-analogue.com
Just another WordPress site
